BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12592136)

  • 1. Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
    Fukuchi K; Yamaguchi M; Hayashida K; Ishida Y
    Clin Nucl Med; 2003 Mar; 28(3):232-3. PubMed ID: 12592136
    [No Abstract]   [Full Text] [Related]  

  • 2. Submandibular gland carcinoma with unusual widespread bone marrow metastases detected by Tc-99m MDP bone scan and FDG PET.
    Ko HL; Tsang YW; Chen YK; Chi KH
    Clin Nucl Med; 2007 Nov; 32(11):866-7. PubMed ID: 18075424
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma.
    Lee J; Park CH; Kim HC; Kim HS
    Clin Nucl Med; 2000 Jul; 25(7):532-5. PubMed ID: 10885695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utility of the scintigraphy with (123)I MIBG in the diagnosis of neuroblastoma bone metastasis].
    Mena Bares LM; Benítez Velazco A; Pérez Cuenca E; Maza Muret FR; Hidalgo Ramos FJ; Pacheco Capote C; Contreras Puertas PI; Latre Romero JM
    Rev Esp Med Nucl; 2009; 28(4):208-9. PubMed ID: 19922836
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
    Iagaru A; Goris ML
    Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1746. PubMed ID: 18648808
    [No Abstract]   [Full Text] [Related]  

  • 8. The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer.
    Brown RS; Dogan A; Ell PJ; Payne HA; Masters JR; Harland SJ
    Prostate Cancer Prostatic Dis; 2002; 5(2):144-51. PubMed ID: 12497005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
    Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
    Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
    J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of Tc-99m HMDP tumor uptake in oat cell carcinoma after irradiation and chemotherapy.
    Shih WJ; Domstad PA; DeLand FH
    Radiat Med; 1986; 4(4):107-9. PubMed ID: 3037615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of FDG-PET scanning in management of lung cancer.
    Coleman RE
    Lancet; 2002 Apr; 359(9315):1361-2. PubMed ID: 11978328
    [No Abstract]   [Full Text] [Related]  

  • 13. Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma.
    Shih WJ; Turturro F; Stipp V; DeSimone P
    Ann Nucl Med; 1996 Nov; 10(4):425-8. PubMed ID: 9006728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
    Ghesani NV; Sun X; Zhuang H; Sam JW; Alavi A
    Clin Nucl Med; 2003 Aug; 28(8):666-7. PubMed ID: 12897654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Foo SS; Ramdave S; Berlangieri SU; Scott AM
    Australas Radiol; 2004 Jun; 48(2):214-6. PubMed ID: 15230758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular lymphoma with bone/bone marrow metastases illustrated by scrotal sonography, spinal MRI, and total body Tc-99m HMDP and Tc-99m MIBI images.
    Shih WJ; Kwolek DS; Lahr B
    Ann Nucl Med; 1999 Oct; 13(5):293-7. PubMed ID: 10582797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell lung cancer presenting as acute leukaemia.
    Ali R; Ozkalemkas F; Ozcelik T; Ozan U; Ozkocaman V; Tunali A; Balaban-Adim S
    Cytopathology; 2005 Oct; 16(5):262-3. PubMed ID: 16181315
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
    Kamel EM; Zwahlen D; Wyss MT; Stumpe KD; von Schulthess GK; Steinert HC
    J Nucl Med; 2003 Dec; 44(12):1911-7. PubMed ID: 14660716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
    Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Fukumura T; Kawai Y; Koga H; Masuda K
    J Nucl Med; 1993 Feb; 34(2):288-90. PubMed ID: 8429349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.